# EDGAR Filing Document

**Accession Number:** 0002069821
**File Stem:** 0000000000-25-008444
**Filing Date:** 2025-8
**Character Count:** 6468
**Document Hash:** 9c76c938b88c2becfb366506fc313048
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008444.hdr.sgml**: 20260520

**ACCESSION NUMBER**: 0000000000-25-008444

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250812

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BILLION GROUP HOLDINGS Ltd
- **CENTRAL INDEX KEY:** 0002069821
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-08064

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 89 NEXUS WAY
- **CITY:** CAMANA BAY
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9009
- **BUSINESS PHONE:** 852 98431101

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 89 NEXUS WAY
- **CITY:** CAMANA BAY
- **PROVINCE COUNTRY:** E9
- **ZIP:** KY1-9009
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-25-049553

## Text-Extract

```

                                                             August 12, 2025

Chan Bun
Chief Executive Officer
Billion Group Holdings Limited
Unit 502, 20-20A
Chung Ying Building
Connaught Road West
Sheung Wan, Hong Kong

       Re: Billion Group Holdings Limited
           Amendment No. 2 to Draft Registration Statement on Form F-1
           Submitted July 31, 2025
           CIK No. 0002069821
Dear Chan Bun:

     We have reviewed your amended draft registration statement and have the
following
comments.

        Please respond to this letter by providing the requested information
and either
submitting an amended draft registration statement or publicly filing your
registration
statement and non-public draft submission(s) on EDGAR. If you do not believe a
comment
applies to your facts and circumstances or do not believe an amendment is
appropriate, please
tell us why in your response.

        After reviewing the information you provide in response to this letter
and your
amended draft registration statement or filed registration statement, we may
have additional
comments. Unless we note otherwise, any references to prior comments are to
comments in
our July 22, 2025 letter.

Amendment No. 2 to Draft Registration Statement on Form F-1 submitted July 31,
2025
Risks Relating to Doing Business in Hong Kong, page 5

1.     We note your response to prior comment 5 and we re-issue the comment. In
your
       summary of risk factors, disclose the risks that your corporate
structure and being
       based in or having the majority of the company   s operations in Hong
Kong poses to
       investors. In particular, describe the significant regulatory,
liquidity, and enforcement
       risks with cross-references to the more detailed discussion of these
risks in the
       prospectus. For example, specifically discuss risks arising from the
legal system in
 August 12, 2025
Page 2

       China, including the risk that the Chinese government may intervene or
influence
       your operations at any time, or may exert more control over offerings
conducted
       overseas and/or foreign investment in China-based issuers, which could
result in a
       material change in your operations and/or the value of the securities
you are
       registering for sale. Acknowledge any risks that any actions by the
Chinese
       government to exert more oversight and control over offerings that are
conducted
       overseas and/or foreign investment in China-based issuers could
significantly limit or
       completely hinder your ability to offer or continue to offer securities
to investors and
       cause the value of such securities to significantly decline or be
worthless. Please note
       that each summary risk factor should have a cross-reference to the
relevant individual
       detailed risk factor.
Our business is affected by the quality and quantity of the products, page 21

2.     We note your response to prior comment 6. Please revise the disclosure
on pages 22
       and 68 to identify the "major supplier" and "Supplier A." respectively.

General terms with customers, page 70

3.     We note your response to prior comment 8. It appears from section 3 of
the
       agreements with customers filed as exhibits 10.6, 10.8 and 10.9 that the
agreements
       are valid from March 25, 2023 to March 24, 2027. However, it appears
from the
       disclosure on page 70 that the initial term is two years. Please advise
or revise
       accordingly.

Consolidated Financial Statements of Billion Group Holdings Limited, page F-1

4.     We note your response to our prior comment 12, that for the years ended
December
       31, 2024 and 2023, the financial statements presented are the combined
financial
       statements of the Company, Harmony Alliance and Billion Enterprise
International
       Limited. However, the financial statements included in the filing are
referred to as
          consolidated financial statements    of Billion Group Holdings
Limited and the audit
       report also refers to consolidated financial statements. In light of the
fact that the
       reorganization has not yet occurred, the audited financial statements
for the years
       ended December 31, 2024 and 2023 included in the filing should be
labeled as
          combined    rather than    consolidated,    and should not be labeled
as those of Billion
       Group Holdings Limited, the registrant, as that entity was not in
existence as of the
       period represented by the financial statements. Consolidated financial
statement
       presentation would not be appropriate without the inclusion of a draft
audit report.
       Additionally, please have your auditor modify its report to refer to the
appropriate
       financial statements.
 August 12, 2025
Page 3

      Please contact Claire Erlanger at 202-551-3301 if you have questions
regarding
comments on the financial statements and related matters. Please contact Thomas
Jones at
202-551-3602 or Jay Ingram at 202-551-3397 with any other questions.

                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of
Manufacturing
cc:   Kyle Leung

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._